These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2504515)

  • 1. Leukocyte and plasma N-laurylsphingosine deacylase (ceramidase) in Farber disease.
    Ben-Yoseph Y; Gagné R; Parvathy MR; Mitchell DA; Momoi T
    Clin Genet; 1989 Jul; 36(1):38-42. PubMed ID: 2504515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls.
    Momoi T; Ben-Yoseph Y; Nadler HL
    Biochem J; 1982 Aug; 205(2):419-25. PubMed ID: 6814427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of Farber disease.
    Fujiwaki T; Hamanaka S; Koga M; Ishihara T; Nishikomori R; Kinoshita E; Furusho K
    Acta Paediatr Jpn; 1992 Feb; 34(1):72-9. PubMed ID: 1580156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity.
    He X; Li CM; Park JH; Dagan A; Gatt S; Schuchman EH
    Anal Biochem; 1999 Oct; 274(2):264-9. PubMed ID: 10527524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A family with combined Farber and Sandhoff, isolated Sandhoff and isolated fetal Farber disease: postnatal exclusion and prenatal diagnosis of Farber disease using lipid loading tests on intact cultured cells.
    Levade T; Enders H; Schliephacke M; Harzer K
    Eur J Pediatr; 1995 Aug; 154(8):643-8. PubMed ID: 7588966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farber disease diagnosed after liver transplantation.
    Salo MK; Karikoski R; Hällström M; Jalanko H; Holmberg C
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):274-7. PubMed ID: 12548066
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulfatide and sphingomyelin loading of living cells as tools for the study of ceramide turnover by lysosomal ceramidase--implications for the diagnosis of Farber disease.
    Levade T; Tempesta MC; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
    Biochem Mol Med; 1995 Apr; 54(2):117-25. PubMed ID: 8581356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells.
    Levade T; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
    J Neurol Sci; 1995 Dec; 134(1-2):108-14. PubMed ID: 8747852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and sensitive assay for alkaline and neutral ceramidases involving C12-NBD-ceramide.
    Tani M; Okino N; Mitsutake S; Ito M
    J Biochem; 1999 Apr; 125(4):746-9. PubMed ID: 10101288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of acid ceramidase deficiency in patients with Farber disease.
    Bär J; Linke T; Ferlinz K; Neumann U; Schuchman EH; Sandhoff K
    Hum Mutat; 2001 Mar; 17(3):199-209. PubMed ID: 11241842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turnover of endogenous ceramide in cultured normal and Farber fibroblasts.
    van Echten-Deckert G; Klein A; Linke T; Heinemann T; Weisgerber J; Sandhoff K
    J Lipid Res; 1997 Dec; 38(12):2569-79. PubMed ID: 9458280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.
    Tohyama J; Oya Y; Ezoe T; Vanier MT; Nakayasu H; Fujita N; Suzuki K
    J Inherit Metab Dis; 1999 Jun; 22(5):649-62. PubMed ID: 10399097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies.
    Chatelut M; Harzer K; Christomanou H; Feunteun J; Pieraggi MT; Paton BC; Kishimoto Y; O'Brien JS; Basile JP; Thiers JC; Salvayre R; Levade T
    Clin Chim Acta; 1997 Jun; 262(1-2):61-76. PubMed ID: 9204210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farber's disease: a fine structural study.
    Abenoza P; Sibley RK
    Ultrastruct Pathol; 1987; 11(4):397-403. PubMed ID: 3113021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic variability in siblings with Farber disease.
    Antonarakis SE; Valle D; Moser HW; Moser A; Qualman SJ; Zinkham WH
    J Pediatr; 1984 Mar; 104(3):406-9. PubMed ID: 6423791
    [No Abstract]   [Full Text] [Related]  

  • 16. A simple method for screening for Farber disease on cultured skin fibroblasts.
    Chatelut M; Feunteun J; Harzer K; Fensom AH; Basile JP; Salvayre R; Levade T
    Clin Chim Acta; 1996 Feb; 245(1):61-71. PubMed ID: 8646815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue accumulation of sulfatide and GM3 ganglioside in a patient with variant Farber disease.
    Fujiwaki T; Hamanaka S; Tate S; Inagaki F; Suzuki M; Suzuki A; Mori C
    Clin Chim Acta; 1995 Jan; 234(1-2):23-36. PubMed ID: 7758220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Farber disease [Farber lipogranulomatosis], acid ceramidase deficiency].
    Koga M
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):389-93. PubMed ID: 9645089
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts.
    Kudoh T; Wenger DA
    J Clin Invest; 1982 Jul; 70(1):89-97. PubMed ID: 6806321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of lysosomes in human diploid fibroblasts from patients with Farber's disease.
    Chen WW; Decker GL
    Biochim Biophys Acta; 1982 Oct; 718(2):185-92. PubMed ID: 6814495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.